Top Markets
Coin of the day
CardioComm Solutions, Inc. CardioComm Solutions, Inc.

CardioComm Solutions, Inc.

EKGGF
Classificação em ações #36976
CardioComm Solutions, Inc., established in 1989 and based in Toronto, Canada,... CardioComm Solutions, Inc., established in 1989 and based in Toronto, Canada, specializes in developing advanced technological solutions for cardiac monitoring. The company delivers both sophisticated software and hardware products, as well as core laboratory reading services, specifically designed for electrocardiogram (ECG) and ambulatory arrhythmia detection systems. These comprehensive offerings cater to both the medical sector and individual consumers across the globe. At the heart of CardioComm's operations is proprietary technology that underpins the entire ECG workflow: from initial recording and seamless transmission to detailed viewing, in-depth analysis, comprehensive reporting, and secure long-term storage. This end-to-end capability is crucial for the effective screening, accurate diagnosis, and ongoing management of cardiac patients. Their unique device connectivity and ECG management platforms are integrated into diverse solutions, spanning general medical applications, consumer-grade health products, clinical research initiatives, and modern telemedicine services. The company's extensive software suite includes the Global ECG Management System (GEMS) for cardiac event monitoring, GlobalCardio 12 Lead—a web-enabled and EMR-compatible ECG device—and GEMS Lite for Windows, an electronic system for receiving ECG data. Complementary software modules further enhance their offerings, such as GEMS WIN Air for live wireless ECG monitoring, AutoAttendant to empower healthcare providers by automating routine tasks, and the GEMS HL7 Interface, which ensures compliant data exchange with other EMR systems. Additionally, GlobalCardio EMR integration facilitates the bi-directional transfer of crucial information, including patient data, reports, and related links. Beyond software, CardioComm provides a range of hardware products. These include the portable HeartCheck PEN and HeartCheck handheld ECG monitors, various Sirona telephonic and wireless event recorders, and the HeartCheck CardiBeat device. Furthermore, the company offers Application Service Provider (ASP) solutions, notably C4 ECG management services and HeartCheck SMART Monitoring. Their broader product portfolio also features GlobalCardio 3 Lead, the ECG Viewer SDK, QRS Diagnostic, and QRS 12 Lead Universal.
Preço da ação
$0.0109
Última sincronização: 2026-08-13
Valor de mercado
$2.15M
Variação (1 dia)
0.00%
Variação (1 ano)
172.50%
País
CA
Negociar CardioComm Solutions, Inc. (EKGGF)

Categoria

Rácio P/E de CardioComm Solutions, Inc. (EKGGF)
Rácio P/E em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da CardioComm Solutions, Inc., o rácio P/E atual (TTM) é 0. No final de 2026, a empresa tinha um P/E de 0.
Histórico do rácio P/E da CardioComm Solutions, Inc. de 2026 a 2026
Rácio P/E no final de cada ano
Ano Índice P/E Alterar
Não há dados suficientes para as datas fornecidas.
Rácio P/E para empresas semelhantes ou concorrentes
Como interpretar um P/E Ratio?

O rácio Preço/Lucro (P/E) mede a relação entre o preço da ação de uma empresa e o lucro por ação.
Um P/E baixo mas positivo representa uma empresa com altos lucros face à sua valorização atual e pode estar subvalorizada. Um P/E negativo elevado (perto de 0) representa perdas significativas.

Empresas com P/E acima de 30 ou negativo são geralmente vistas como "ações de crescimento", significando que os investidores esperam crescimento ou rentabilidade futura.

Empresas com P/E positivo inferior a 10 são geralmente consideradas "ações de valor", ou seja, já são muito lucrativas mas com pouco potencial de crescimento.